Keyphrases
Percutaneous Coronary Intervention
79%
Transcatheter Aortic Valve Replacement
51%
Taxus
48%
Paclitaxel-eluting Stent
41%
ARRIVE
38%
Stent Thrombosis
35%
Clinical Outcomes
33%
Adverse Cardiac Events
24%
Drug-eluting Stent
24%
Myocardial Infarction
24%
High Risk
23%
Target Lesion Revascularization
22%
Stent
22%
Coronary Stent
20%
Transcatheter Closure
19%
Mitral Regurgitation
18%
United States
17%
Patent Foramen Ovale
16%
Surgical Aortic Valve Replacement
16%
2-year Outcome
16%
In-stent Restenosis
16%
Amplatzer
15%
Perimembranous Ventricular Septal Defect
15%
Revascularization
14%
Cardiogenic Shock
14%
Severe Aortic Stenosis
14%
Percutaneous Repair
13%
Delayed Revascularization
13%
Fractional Flow Reserve
13%
Coronary Bifurcation Lesions
13%
Restenosis
13%
Acute Coronary Syndrome
12%
Clinical High Risk
12%
Randomized Trial
12%
Aortic Stenosis
12%
Confidence Interval
12%
Balloon
11%
Paclitaxel
11%
Left Atrium
11%
Muscular Ventricular Septal Defect
11%
Pseudoaneurysm
11%
Patient Demographics
10%
Randomized Controlled Trial
10%
Intracoronary Stenting
10%
Ostial Lesion
10%
Long-term Clinical Outcome
10%
Multivessel
9%
Randomized Comparison
9%
Intra-aortic Balloon Pump
9%
Mortality Rate
9%
Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Percutaneous Aortic Valve Replacement
51%
Paclitaxel
45%
Stenting
38%
Stent Thrombosis
34%
Myocardial Infarction
33%
Drug-Eluting Stent
33%
Ventricular Septal Defect
27%
Aortic Stenosis
26%
Revascularization
25%
Patent Foramen Ovale
23%
Mitral Insufficiency
22%
Target Lesion Revascularization
22%
Cardiovascular System
19%
In-Stent Restenosis
19%
Coronary Artery Disease
17%
Health Care Cost
16%
Atrial Septal Defect
15%
Cardiogenic Shock
15%
Pseudoaneurysm
15%
Surgery
14%
Restenosis
14%
Randomized Controlled Trial
13%
Fractional Flow Reserve
13%
Coronary Bifurcation Lesion
13%
Acute Coronary Syndrome
12%
Infarction
12%
Hemodynamic
12%
Assisted Circulation
12%
Aortic Valve Replacement
12%
Surgeon
11%
Combination Therapy
11%
Mortality Rate
11%
Cardiac Catheterization
11%
Transluminal Coronary Angioplasty
10%
Left Atrium
10%
Ventricular Assist Device
9%
Patient Population
9%
Comorbidity
9%
Rapamycin
9%
Heart Disease
9%
Laser Angioplasty
9%
Coronary Artery Obstruction
9%
Coronary Artery Dissection
9%
Valve Replacement
9%
Intravascular Ultrasound
9%
Brachytherapy
8%
Mitral Valve
8%
Odds Ratio
8%
Bleeding
8%
